1. Home
  2. CVLT vs GRFS Comparison

CVLT vs GRFS Comparison

Compare CVLT & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commvault Systems Inc.

CVLT

Commvault Systems Inc.

HOLD

Current Price

$168.49

Market Cap

6.8B

Sector

Technology

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$7.46

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVLT
GRFS
Founded
1996
1940
Country
United States
Spain
Employees
3300
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.2B
IPO Year
2006
2008

Fundamental Metrics

Financial Performance
Metric
CVLT
GRFS
Price
$168.49
$7.46
Analyst Decision
Buy
Buy
Analyst Count
19
2
Target Price
★ $163.49
$10.87
AVG Volume (30 Days)
★ 497.2K
457.1K
Earning Date
10-27-2026
07-28-2022
Dividend Yield
N/A
★ 1.41%
EPS Growth
N/A
★ N/A
EPS
★ 0.50
N/A
Revenue
★ $1,183,690,000.00
N/A
Revenue This Year
$10.32
$2.15
Revenue Next Year
$11.31
$6.22
P/E Ratio
$328.55
★ $18.67
Revenue Growth
★ 18.89
N/A
52 Week Low
$71.75
$6.96
52 Week High
$175.03
$9.90

Technical Indicators

Market Signals
Indicator
CVLT
GRFS
Relative Strength Index (RSI) 65.79 48.57
Support Level $127.70 $7.38
Resistance Level N/A $7.65
Average True Range (ATR) 6.26 0.16
MACD 0.73 0.03
Stochastic Oscillator 93.60 48.33

Price Performance

Historical Comparison
CVLT
GRFS

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides cyber resiliency solutions designed to help the enterprise protect, secure, and recover its data, applications, and identity systems in a world of increasing cyber threats and attacks. Its offerings provide cyber resilience, including data protection, cyber recovery, data security, and governance, aiming to enable customers to continue business. The company delivers its solutions through Commvault Cloud, a cloud native platform that unifies data security, cyber recovery and identity resilience across on-premises, hybrid, multi-cloud, and software-as-a-service environments. It sells its offerings through subscription-based arrangements, including SaaS and term-based subscriptions, and also offers perpetual licenses, customer support, and professional services.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: